Welcome to MedX – Your Source for the Latest Medical Breakthroughs! FDA Approves First Treatment for IgG4-Related Disease – Inebilizumab becomes the first and only FDA-approved therapy for this rare, multi-organ immune condition, cutting flares by 87% in Phase 3 trials. Atrasentan Offers New Hope for IgA Nephropathy – The FDA grants accelerated app
3332 Reached1 Comments1 Likes
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Case of Pulmonary Embolism with Syncope
544 Reached4 Likes
Use of Clindamycin for Managing Bacterial Vaginosis
10824 Reached28 Comments8 Likes
Chronic Hyperplastic Candidiasis Of The Oral Mucosa
856 Reached9 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes